Key result
Adding 44 plasma proteins to Framingham Risk Score improves vascular aging classification to AUC ~0.91.
Why the study?
Vascular aging is the pathological basis of cardiovascular diseases, but its underlying molecular mechanisms remained unclear.
Does integrating 44 plasma proteins with the Framingham Risk Score improve vascular aging classification and risk stratification across vascular diseases compared to the Framingham Risk Score alone?
Observational (n=42,326)
Does integrating 44 plasma proteins with the Framingham Risk Score improve vascular aging classification and risk stratification across vascular diseases compared to the Framingham Risk Score alone?
Integrating 44 circulating vascular aging-associated proteins with the Framingham Risk Score improves vascular aging classification (AUC 0.911) and identifies functionally supported protein candidates involved in endothelial and pericyte senescence.
Answers are grounded in this paper and cite their sources.
May support protein-enhanced vascular aging models in research; leaves open clinical adoption pending prospective validation.
Vascular aging (VA) is the pathological basis of cardiovascular diseases, but its molecular mechanisms are unclear. Analyzing 2920 proteins in 42,326 participants, we identified 44 VA-associated proteins via logistic regression with prespecified age/sex stratification. An internally cross-validated machine-learning model integrating these proteins with the Framingham Risk Score (FRS) improved VA classification (AUC 0.911), reclassifying 14.8% of individuals beyond FRS. Risk tertiles showed distinct survival curves across six vascular diseases over 15 years. Mendelian randomization prioritized 11 of the 44 proteins in relation to arterial stiffness index; nine were differentially expressed in human serum or aged mouse arterial tissues. Using VA-related cynomolgus arterial single-cell RNA-seq, six of these nine showed cell-type–specific expression changes in endothelial cells and pericytes. In these cell types, knockdown of IGFBP2 and LAYN aggravated senescence-related phenotypes, whereas that of FAM20A, ERBB2, and SMAD5 attenuated them under the conditions examined. Our findings characterize circulating proteomic alterations associated with VA and identify candidates for future biomarker and mechanistic studies.
No takes yet. Share an insight, caveat, or question.
Hanchen et al. (2026) conducted an observational in Vascular aging and vascular diseases (n=42,326). 44 vascular aging-associated plasma proteins integrated with Framingham Risk Score vs. Framingham Risk Score alone was evaluated on Vascular aging classification (AUC 0.911). Integrating 44 vascular aging-associated plasma proteins with the Framingham Risk Score improved vascular aging classification and reclassified 14.8% of individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: